Hasil Pencarian - Thomas Evers

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States.

    Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States. oleh Craig I Coleman, Muralikrishna Tangirala, Thomas Evers

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product Profile

    Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product Profile oleh Christoph Gerlinger, Thomas Evers, Jeremy Rassen, Richard Wyss

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Coste-efectividad de la adición de acarbosa al tratamiento de pacientes con diabetes tipo 2 en España Cost-effectiveness of the addition of acarbose to the treatment of patients with type-2 diabetes in Spain

    Coste-efectividad de la adición de acarbosa al tratamiento de pacientes con diabetes tipo 2 en España Cost-effectiveness of the addition of acarbose to the treatment of patients wi... oleh Carme Piñol, Stephane Roze, William Valentine, Thomas Evers

    Diterbitkan 2007-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain

    Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain oleh Carlos Rubio-Terrés, Ruth Graefenhain de Codes, Darío Rubio-Rodríguez, Thomas Evers, Santiago Grau Cerrato

    Diterbitkan 2016-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes

    Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes oleh Richard Sheer, Radhika Nair, Margaret K. Pasquale, Thomas Evers, Meghan Cockrell, Alain Gay, Rakesh Singh, Niklas Schmedt

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan

    Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan oleh Suguru Okami, Coralie Lecomte, Hanaya Raad, Mireia Aguila, Zuzana Mohrova, Makiko Takeichi, Takanori Tsuchiya, Christoph Ohlmeier, Thomas Evers, Alexander Michel

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Author Correction: Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan

    Author Correction: Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan oleh Suguru Okami, Coralie Lecomte, Hanaya Raad, Mireia Aguila, Zuzana Mohrova, Makiko Takeichi, Takanori Tsuchiya, Christoph Ohlmeier, Thomas Evers, Alexander Michel

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: